Ocular Therapeutix OverviewOcular Therapeutix EBIT
EBIT (Earnings Before Interest and Taxes) analysis for OCUL.
Quarterly EBIT
-$94.62M
↓ 41.15% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$295.60M
↓ 46.4% YoY
Trailing 12 months ending Mar 31, 2026
Ocular Therapeutix OverviewEBIT (Earnings Before Interest and Taxes) analysis for OCUL.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026